Article Per Year (5 Year)
p-Index From 2021 - 2026
0.61
P-Index
This Author published in this journals
All Journal Sehat Rakyat: Jurnal Kesehatan Masyarakat JOURNAL OF Mother and Child Health Concerns
Reny Haryani
Institut Teknologi Sumatera
Dentistry Health Professions Medicine & Pharmacology Nursing Public Health Veterinary

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Evaluasi resep obat batuk anak di salah satu apotek Reny Haryani; Lailatul Kasanah; Rastria Meilanda
THE JOURNAL OF Mother and Child Health  Concerns Vol. 4 No. 7 (2025): October Edition
Publisher : Indonesian Public Health-Observer Information Forum (IPHORR) Kerjasama dengan Persatuan Perawat Nasional Indonesia (PPNI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56922/mchc.v4i6.1601

Abstract

Background: Prescription review is an evaluation of prescription writing conducted by pharmaceutical personnel, covering administrative, pharmaceutical, and clinical aspects. Prescription review is an important step in preventing medication errors. Purpose: to determine the appropriateness of prescriptions for children's cough medicine. Method: This study used a non-experimental design with a descriptive approach. The sampling technique was simple random sampling. Based on calculations using the Slovin formula, 96 prescriptions were obtained, which were then rounded up to 100 prescriptions as the research sample. Results: The study showed the completeness of administrative aspects included: patient name (100%), age (100%), gender (0%), weight (0%), doctor's name (100%), and doctor's SIP number (51%). In the pharmaceutical aspect, the results obtained were dosage strength (1%), route of administration (100%), and drug combination suitability (100%). Meanwhile, in the clinical aspect, the results were: drug interaction suitability (94%), drug dosage (88%), drug administration route and allergy history (100%), and contraindications (100%). Conclusion: Prescriptions for children's cough medicine for the period January–December 2022 generally complied with the standards set out in Regulation of the Minister of Health of the Republic of Indonesia Number 73 of 2016.
Effectiveness and safety of oral versus intravenous iron therapy in iron deficiency anemia during pregnancy: A pharmacological review Reny Haryani; Juwana Janu
THE JOURNAL OF Mother and Child Health  Concerns Vol. 5 No. 1 (2026): April Edition 2026
Publisher : Indonesian Public Health-Observer Information Forum (IPHORR) Kerjasama dengan Persatuan Perawat Nasional Indonesia (PPNI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56922/mchc.v5i1.3058

Abstract

Background: Iron deficiency anemia is a global health problem commonly occurring during pregnancy. The World Health Organization reported a prevalence of 35.5% in 2023, which may lead to serious consequences for both mother and fetus. Management of this condition is generally carried out through oral or intravenous iron therapy, each having its own advantages and limitations. Purpose: to evaluate the effectiveness and safety of oral versus intravenous iron therapy in pregnant women with iron deficiency anemia. Method: A limited systematic review was conducted based on PRISMA guidelines. Literature searching was performed using the PubMed database for studies published between 2015 and 2025. A total of 75 articles were identified, of which 5 studies met the inclusion criteria and were analyzed descriptively. Results: The findings showed that intravenous iron therapy, particularly ferric carboxymaltose, was more effective in increasing hemoglobin and ferritin levels compared to oral therapy. In terms of safety, oral iron was more frequently associated with gastrointestinal side effects, whereas intravenous iron was generally well tolerated with mild adverse effects. Conclusion: Intravenous iron therapy demonstrates superior effectiveness in improving hematological parameters; however, oral iron remains the first-line therapy due to its accessibility and lower cost. Therefore, treatment selection should be individualized based on the patient’s clinical condition.
Efektivitas Metformin dalam Meningkatkan Kehamilan Klinis dan Angka Kelahiran Hidup pada Wanita dengan PCOS: Tinjauan Naratif dengan Implikasi bagi Kesehatan Masyarakat Juwana Janu; Reny Haryani
Sehat Rakyat: Jurnal Kesehatan Masyarakat Vol. 4 No. 3 (2025): Agustus 2025
Publisher : Yayasan Pendidikan Penelitian Pengabdian Algero

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54259/sehatrakyat.v4i3.5320

Abstract

Infertility due to ovulatory disorders presents a significant challenge in reproductive health, with Polycystic Ovary Syndrome (PCOS) being one of the leading causes. Metformin has been widely used in clinical practice to manage ovulatory dysfunction in women with PCOS, either as monotherapy or in combination with other therapeutic approaches. This narrative review aims to evaluate the effectiveness of metformin on clinical pregnancy rate (CPR) and live birth rate (LBR) through a critical appraisal of nine scientific publications published in the past ten years. Relevant literature was gathered through the PubMed database using selected keywords and screened based on predefined inclusion and exclusion criteria. Findings indicate that metformin provides beneficial effects on improving CPR, particularly when used as an adjunct therapy prior to IVF protocols or in combination with non-pharmacological approaches such as acupuncture. However, evidence related to LBR demonstrates greater variability. Overall, these findings support the role of metformin as part of an individualized, evidence-based fertility treatment strategy. This review offers important clinical implications for optimizing infertility management in women with PCOS.
Co-Authors Juwana Janu Lailatul Kasanah Rastria Meilanda